Hey All,
It is estimated that 22 million+ people in the U.S. suffer from asthma,making it one of the most common and costly of all diseases. One quarter of all emergency room visits are asthma related and asthma is the one of the leading chronic childhood diseases.Controlling inflammation of the airways has become the central focus for managing asthma. Strong clinical evidence suggests
that asthma management and control can be significantly improved by regularly monitoring airway inflammation. However,current methods used to monitor and manage asthma, such as lung function tests, do not measure airway inflammation.
Physicians have relied largely on correlating symptoms and disease severity to assess their patients. Until now, the degree of airway inflammation has not been measurable in a simple and practical way. The eNO Solution Exhaled nitric oxide has been established as a reliable marker of airway inflammation in asthma for over 10 years. It has been the central focus of studies, establishing its link to optimization of medication and prediction of asthma exacerbations. Measurement of eNO in the physicianâs office is a much awaited breakthrough in medical technology that provides physicians with a reliable tool to measure airway inflammation as an adjunct to the current diagnostic measures, such as lung function.
Asthma is a chronic disease characterized by inflammation of the airways caused by allergens and other triggers. When airways are inflamed, the inner walls of the airways swell making them irregular. This causes the flow of air to become turbulent. The events that lead to obstruction of airflow and thus to asthma symptoms are complex and usually involve the following events:Bronchoconstriction, where the smooth muscle surrounding the airways tightens in response to a trigger and narrows the airway.
Source:http://www.apieron.com/asthma-infor
mation-downloads/Exhaled-Nitric-Oxide-Reso
urce-Kit.pdf